about
Opportunities and Challenges for Drug Development: Public-Private Partnerships, Adaptive Designs and Big DataPermitting patients to pay for participation in clinical trials: the advent of the P4 trial.ClinicalTrials.gov, stem cells and 'pay-to-participate' clinical studies.Personalized medicine: the enabling role of nanotechnology.A Plutocratic Proposal: an ethical way for rich patients to pay for a place on a clinical trial.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical research: Should patients pay to play?
@en
type
label
Clinical research: Should patients pay to play?
@en
prefLabel
Clinical research: Should patients pay to play?
@en
P2860
P50
P1476
Clinical research: Should patients pay to play?
@en
P2093
Govind Persad
Steven Joffe
P2860
P304
P356
10.1126/SCITRANSLMED.AAC5204
P407
P577
2015-07-01T00:00:00Z